Represent pharmaceutical, medical device and diagnostic companies, as well as other healthcare related clients in various investigations into potential violations of the False Claims Act, the Anti-Kickback Stature and other related regulations.
Led internal investigations for clients across a broad range of industries involving potential violations of the FCPA in Asia, Africa, Europe, Central America and South America.
Represented pharmaceutical company in negotiations with DOJ and the SEC to resolve significant FCPA investigation, including subsequent required compliance disclosures and interactions with the appointed independent monitor.
Represented a different pharmaceutical company in negotiations with DOJ and various states Attorneys General that resolved significant off-label marketing investigation into a drug with annual sales of more than $1 billion.
Represented a telecommunications company in disclosures to DOJ regarding potential violations of the FCPA.
Represent senior executives of large publicly traded companies in FCPA investigations before DOJ and the SEC.
Represent founder and CEO of medical device company in negotiations with DOJ that resolved allegations the sales staff of the company was providing kickbacks to healthcare professionals.
Represented large transportation company in SEC investigation into client’s corporate governance.
